WILMINGTON, Mass., June 21 /PRNewswire-FirstCall/ -- CardioTech International, Inc. , a developer and manufacturer of advanced medical device products for the treatment of cardiovascular and other diseases, announced today that it will release its fourth quarter and fiscal year 2006 financial results before the market opens on Wednesday, June 28, 2006. Following the release, the Company will host a conference call for investors at 2:30 p.m. ET (11:30 a.m. PT) to discuss its fiscal fourth quarter and 12 month results.
Participants should dial-in (866) 206-7204, Conference ID# 924000. Please dial-in 10 minutes before the call is scheduled to begin.
About CardioTech International:
CardioTech International, Inc. is a medical device company that develops, manufactures and sells advanced products for the treatment of cardiovascular and other diseases. CardioTech is currently developing new products that address annual overall worldwide markets exceeding $1 billion. CardioPass(TM) is CardioTech’s proprietary, synthetic coronary artery bypass graft. The Company is partnering with CorNova to develop a drug-eluting stent.
CardioTech’s corporate headquarters are located in Wilmington, Massachusetts, with operations in California and Minnesota. The Company generates revenues from sales of advanced medical devices and disposables used during cardiopulmonary bypass procedures, as well as from contracted product design and development services. More information about CardioTech is available at its website: http://www.cardiotech-inc.com.
Contact: Eric Walters Vice President & Chief Financial Officer CardioTech, International, Inc. 978-657-0075 general-info@cardiotech-inc.com Sylvia Dresner Senior Vice President VMW Corporate & Investor Relations 212-616-6161 info@vmwcom.com
CardioTech International, Inc.
CONTACT: Dr. Michael Szycher of CardioTech International, Inc.,+1-978-657-0075
Web site: http://www.cardiotech-inc.com/
